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The successful use of herbal combinations in managing diseases or conditions over a single herb has lead us to evaluate the anti-
dyslipidemic properties of the combination of the artichoke leaves extract, turmeric extract, prickly pear dried leaves (PPL) and
garlic extract versus each one alone in two diﬀerent hyperlipidemic animal models. A two-week treatment of each of the natural
extracts, combination 1 (artichoke, turmeric and PPL) or combination 2 (artichoke, turmeric, PPL and garlic) prior to a single
intraperitoneal injection of Pluronic F-127 resulted in decreasing signiﬁcantly serum LDL levels by garlic and PPL extracts and
serum LDL/HDL ratios by turmeric, PPL, combination 1 and 2. In a 10-day high fat diet model, only the combination 1 and 2
lowered serum cholesterol, LDL by 8–12%, decreased signiﬁcantly triglycerides, LDL/HDL ratio; and increased signiﬁcantly HDL
(P<0.0001). However, a long term treatment of each natural product for 7 weeks resulted in decreasing signiﬁcantly serum LDL
levels and LDL/HDL ratio (P<0.05–0.0001). Furthermore, only artichoke and PPL inhibited signiﬁcantly HMG-CoA reductase
activity (P<0.05). In conclusion, short term, as well as long term, treatment using the combination of artichoke, turmeric, PPL
and garlic extract prevents dyslipidemia; partially through inhibiting HMG-CoA reductase.
1.Introduction
Dyslipidemia can be deﬁned as the elevation of cholesterol,
triglycerides, and low-density lipoprotein (LDL) cholesterol
serum levels while maintaining low serum levels of high-
density lipoprotein (HDL) cholesterol. This imbalance is
consideredahigh-riskfactorforinducingatherosclerosisand
cardiovascular diseases (CVD). CVD is now considered the
most common cause of death in both western and eastern
countries [1].
Traditionally, natural remedies were used to overcome
such imbalance in lipids metabolism and are claimed to
be useful in controlling hyperlipidemia and associated
pathologies [2]. Plants such as artichoke (Cynara scolymus)
is an important component of the Mediterranean diet and it
is rich in bioactive phenolic compounds, inulin, ﬁbers, and
minerals [3]. Traditionally, artichoke leaves were used for a
variety of diseases [4]. It has been used to treat dyspepsia
mainly because of its choleretic eﬀect that is associated with
increased bile formation [5]. In addition, artichoke extract
has been found to exhibit antioxidant properties in cultured
endothelial cells and monocytes [4] and has lipid lowering
properties [3, 6–8].
Curcuma longa, commonly known as turmeric, is a
rhizomatous perennial plant from the family Zingiberaceae
[9, 10]. Curcumin has been identiﬁed as the principle active
component of turmeric that is responsible for many phar-
macological properties [11] including anti-inﬂammatory,
powerful antioxidant activity [12], and cancer-preventive
properties [13]. Also, it lowers blood glucose and glycated2 ISRN Pharmacology
hemoglobin levels by lowering oxidative stress in diabetic
rats [14, 15] .Sev e ra ls t u d i e sh a v er e po rt edt h a tc u r c u m i nh a s
h y p o l i p e m i ca c t i o ni nr a t s[ 16]. It lowers serum cholesterol
levels in diet induced hyperlipidemia [17] and triglycerides
in alcohol induced toxicity [18]. It also increases cholesterol
fecal excretion [19] and induces changes in gene expression
involved in cholesterol homeostasis [20].
Prickly pear cactus (Opuntia ﬁcus-indica)i sat r e el i k e
cactus from the family Cactaceae [21]. The dried leaves
of prickly pear cactus have been considered as one of the
functional food by embracing essential ingredients, such as
amino acids, taurine, carbohydrates, vitamin C, minerals,
and soluble ﬁbers [22]. Prickly pear owns well-known
antidiabeticandlipidloweringproperties[23].Also,itisvery
useful in obesity, alcohol-induced hangover, colitis, diarrhea,
and benign prostatic hypertrophy (BPH) [24]. Many uses
of cladodes (leaves) of cactus pear have been reported and
utilized for their hypolipidemic properties [21, 24, 25].
Evidence showed that cactus pear reduces cholesterol levels
in human and modify LDL composition [22].
Garlic (Allium sativum) from the family Alliacae is used
as spice and medicinal herb [26]. It is used as raw, cooked,
dried, and in form of tablets [27]. Garlichas protective
actions against cardiovascular diseases. Numerous studies
suggest that garlic can normalize serum lipids, enhances
ﬁbrinolytic activity, and reduces blood pressure [28].
The successful use of herbal combinations in treating
or managing diseases or conditions over a single herb [29,
30] has led us to evaluate the antidyslipidemic properties
of the combination of the above natural extracts versus
each one alone in two diﬀerent hyperlipidemic models [31].
Furthermore, in order to study the mechanism of action
of each constituent, each product was tested in inhibiting
the activity of HMG-CoA reductase enzyme. The long-term
objective of this study, however, is enhancing the use of these
natural extracts in lowering serum levels of cholesterol, LDL
and triglycerides, and increasing serum HDL in order to
reduce CVD and their adverse consequences.
2.MaterialsandMethods
2.1. Materials. Pluronic F-127, cholesterol and cholic, acid
were obtained from Sigma-Aldrich, USA. Corn oil and
Atorvastatin were supplied by the Jordanian Pharmaceutical
Manufacturing Company (JPM). Artichoke leaves powdered
extract (>2.5% caﬀeolquinic acid) was purchased from
Finzelberg, Germany; cactus dried leaves (>35% edible
ﬁbers) from Bioserae, France; common turmeric extract
(Curcumins >97.5%) from Xi’an Tianxing Natural Bio-
ProductsCoLtd,China,garlicpowderextract(Alliin>3.4%)
from Flachsmann, Canada. The natural extracts were used
as supplied and no attempts were carried to evaluate their
compositions.
2.2. Animals and Treatments. Experiments were carried out
on adult Spargue Dawley (SD) male rats weighing (200–
250g). The animals were housed in an air-conditioned
environment under a daily photoperiod 12h light/12h dark
cycle and received standard chow and tap water ad libitum.
Animals were kept for 2 weeks to allow acclimatization
to the animal facility before starting the experiments. All
experiments on animals were performed following the
standards of European Community Council Directive of
November 24, 1986 (86/609/EEC). The study protocol was
revised and approved (9/2008) by the Ethical Committee of
the Faculty of Pharmacy and Medical Sciences, University of
Petra, Amman, Jordan.
2.3.HyperlipidemiaInductionUsingPluronicF-127. Pluronic
F-127 is a nontoxic, hydrophilic nonionic surfactant that
is administered parenterally in rodents to induce reversible
hyperlipidemia [32–34]. Pluronic F-127 solution was pre-
pared by dissolving the corresponding dose in cold normal
saline and kept in the refrigerator overnight for complete
dissolution. Twenty-four hours before the experiment, only
water was oﬀered to the rats. Treated groups (n = 8/time
point) received a single intraperitoneal (i.p) injection of
300mg/kg of Pluronic F-127. The controls were injected
with normal saline only. During the 48h of the experiment,
blood samples at 0, 4, 12, 24, and 48h were drawn. At each
time point, rats were sacriﬁced under anesthesia and blood
samplesweredirectlycollectedfromtheheart.Bloodsamples
were allowed to clot for 15 minutes and then centrifuged.
Serum samples were kept frozen at −20◦C until date of
analysis.
2.4. Hyperlipidemia Induction Using High-Fat Diet. High-fat
diet consisted of standard diet mixed with 10% corn oil,
1% cholesterol, and 0.2% cholic acid. For this method of
induction, rats were divided in two groups; group 1: control,
fed with the normolipidemic diet, and group 2: fed with the
cholesterolbasedformula.Allgroupshadfreeaccesstowater.
After 10 days of feeding, fasting rats were sacriﬁced under
anesthesia. Blood samples were taken directly from the heart
and processed as previously described.
2.5. Antihyperlipidemic Eﬀect of the Natural Extracts. To
investigate the eﬀect of the natural extracts to prevent
the elevation of blood lipids, animals were divided into 8
groups with eight rats in each group. Each group received
daily either water, atorvastatin 10mg/kg, artichoke leaves
extract 26mg/kg, turmeric 80mg/kg, prickly pear leaves
(PPL) 22mg/kg, garlic 17mg/kg, combination 1 (artichoke,
turmeric, and PPL), or combination 2 (artichoke, turmeric,
PPL, and garlic). These doses correspond to the human
recommended daily doses of 1.8, 5.6, 1.5, and 1.2g/day
for artichoke, turmeric, PPL, and garlic, respectively [6,
18, 35, 36]. At the beginning of each experiment, rats
were treated orally using an intragastric tube and they had
free access to water and normal diet. In Pluronic F-127
inducedhyperlipidemia,ratsweredividedinto9groups(n =
6/group). Group 1 served as negative control. For 2 weeks,
rats were orally treated with the previously described doses
and had free access to water and normal diet. Twenty-four
hours before the last sample treatment, hyperlipidemia was
induced using a single i.p injection of 300mg/kg PluronicISRN Pharmacology 3
F-127 after 24h fasting. Group 1 was injected with normal
salineonly.Attheendoftheexperiment,bloodsampleswere
collected from the hearts, centrifuged and kept at −20◦C
until analysis. In High-Fat diet modeland after 14 days of
treatment, rats were switched to be fed with High-Fat diet
(10% corn oil, 1% cholesterol, and 0.2% cholic acid) along
with the treatment. At the last day of the study, all animals
were kept fasting (except for water) for 24h before blood
samples were collected directly from the heart and processed
as previously described.
2.6. Biochemical Assay of Serum Lipids. Serum total choles-
terol, triglycerides, and LDL were determined by enzymatic
methodusingAnalyticonBiotechnologiesAG,Germanykits,
while HDL was measured by using Labkit, Chemelex, S.A.
The absorbance was measured at 546nm wavelength using
RA-50 Chemistry Analyzer, Technicon, USA.
2.7. HMG-CoA Reductase Activity Assay. The eﬀect of the
natural extracts on the activity of HMG-CoA reductase was
assayed using an enzymatic assay kit from Sigma-Aldrich,
USA.
2.8. Statistical Analysis. Results are expressed as mean ±
S.E.M (standard error of the mean). Data obtained were
analyzed by ANOVA followed by Dunnett as post hoc test
using SPSS program, version 17. P values less than 0.05 were
considered signiﬁcant.
3. Results
3.1. Pluronic F-127 versus High-Fat Diet. Administration of
Pluronic F-127 led to very high serum levels of triglycerides,
cholesterol, and LDL, but not HDL in rats (Figure 1). After
4h, the increase in cholesterol and LDL was not signiﬁcant
as it is compared to the control, while triglycerides level
increased signiﬁcantly (P < 0.05). The increase in serum
lipid levels continued till it reached a peak level at 24h
and plateaued for 48h following the injection (P < 0.0001).
However, the elevation in triglyceride level was much higher
than cholesterol and LDL (Figure 1). Giving High-Fat diet
to rats for 10 days, on the other hand, resulted in a
signiﬁcant increase in serum cholesterol, LDL, LDL/HDL
ratio, and triglycerides (P < 0.001, 0.001, 0.001, and 0.05,
resp.) (Table 1).
3.2. Antihyperlipidemic Eﬀect of the Natural Extracts in
Pluronic F-127 Induced Hyperlipidemia. A two-week treat-
ment of PPL and garlic extracts prior to a single i.p
injection of 300mg/kg Pluronic F-127 resulted in decreasing
signiﬁcantly serum LDL levels (P < 0.05) (Table 2). However,
turmeric,PPL,and both combinations resulted indecreasing
LDL/HDL ratios signiﬁcantly (P < 0.05, 0.001). Atorvastatin,
on the other hand, did not cause any signiﬁcant eﬀect
on serum lipid levels induced by Pluronic administration
(Table 2).
Table 1: Eﬀects of high-cholesterol diet on the serum lipid proﬁle
of rats.
Parameter (mg/dL) Control∗
n = 6
High-cholesterol diet∗
n = 6
Total cholesterol 61 ± 59 4 ± 3a
Triglyceride 72 ± 59 2 ± 4b
HDL 19 ± 21 5 ± 2
LDL 52 ± 48 2 ± 2a
LDL/HDL 2.9 ± 0.3 6.2 ± 0.7a
Data presented as means ± SEM (standard error of the mean).
∗Animals were fed high-cholesterol diet for 10 days.
Control animals received normal diet.
aP<0.001 and bP<0.05 versus control.
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Figure 1: Changes in serum lipid levels at diﬀerent times following
a single i.p injection of 300mg/kg Pluronic F-127. Values are
presentedasmeans ±SEM,withn = 8foreachdatapoint.Symbols
mean statistically signiﬁcant; #P < 0.05, ∗P<0.0001, compared to
control. Signiﬁcant values for cholesterol are the same for LDL.
3.3.AntihyperlipidemicEﬀectoftheNaturalExtractsandTheir
Combinations in High-Fat Diet-Induced Hyperlipidemia.
Treating the rats for 2 weeks either with a single product or
with diﬀerent combinations and then giving them High-Fat
diet for only 10 days (with the treatment) gave the following
results: none of the single product changed the level of
any serum lipid proﬁles; the ﬁrst combination (artichoke,
turmeric and PPL) and the second one (artichoke, turmeric,
PPL and garlic) lowered cholesterol and LDL levels by 8–
12%; decreased signiﬁcantly serum triglycerides, LDL/HDL
ratio, and increased signiﬁcantly HDL levels (P < 0.0001)
(Figure 2). On the other hand, Atorvastatin decreased signif-
icantly serum cholesterol, LDL levels (P < 0.05), LDL/HDL
ratio (P < 0.0001), triglycerides (P < 0.0001), and increased
signiﬁcantly HDL levels (P < 0.0001).
However, keeping the rats under High-Fat diet for
another 25 days (i.e., 5 weeks in total) resulted in a drop of
serum cholesterol level in the control group that abolishes
the signiﬁcance eﬀect of Atorvastatin on cholesterol level.
However, all the natural extracts, except for PPL, and
Atorvastatin resulted in a signiﬁcant decrease in triglycerides
levels (P < 0.01–0.0001) (Table 3). The decrease in LDL level
was also signiﬁcant for all groups (P < 0.05–0.01) except4 ISRN Pharmacology
Table 2: The eﬀect of the natural extracts and their combinations on serum lipid levels in Pluronic F-127 induced hyperlipidemia.
Groups Serum Lipid Parameters (mg/dL)
Cholesterol Triglycerides HDL LDL LDL/HDL
Normal 75 ± 26 4 ± 63 9 ± 56 5 ± 11 . 9 ± 0.2
Control Pl. 455 ± 30 2894 ± 206 33 ± 3 378 ± 23 11.5 ± 0.7
Atorvastatin 460 ± 14 3021 ± 176 26 ± 2 377 ± 13 14.7 ± 1.1
Artichoke 523 ± 44 3504 ± 160 41 ± 8 415 ± 39 11.7 ± 2.3
Turmeric 487 ± 20 3365 ± 153 43 ± 2 387 ± 18 9.1 ± 0.8a
PPL 388 ± 17 2888 ± 190 50 ± 3 308 ± 15a 6.2 ± 0.5b
Garlic 389 ± 17 3020 ± 198 25 ± 2 313 ± 14a 12.9 ± 1.4
Comb. 1 573 ± 28 3723 ± 159 57 ± 4 472 ± 24 8.3 ± 0.4a
Comb. 2 510 ± 37 3253 ± 204 54 ± 2 413 ± 33 7.7 ± 0.7a
Datapresentedasmeans±SEMwith6ratsineachgroup.ControlPl.:controlgroupgivenonlyPluronicF-127.PPL:pricklypearleaves.Comb.1:combination
1 (artichoke, turmeric, and PPL). Comb. 2: combination 2 (artichoke, turmeric, PPL, and garlic). Statistical analysis was done using ANOVA, aP<0.05, and
bP<0.0001 compared to control Pl.
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Figure 2: The eﬀect of the two combinations on serum lipid
levels in comparison with the single treatment. Atorva: atorvastatin
10mg/kg. PPL: prickly pear leaves. Comb. 1: combination 1
(artichoke,turmeric,andPPL).Comb.2:combination2(artichoke,
turmeric, PPL, and garlic). Values are presented as means ± SEM,
with n = 8 for each data point. Symbols mean statistically
signiﬁcant; #P < 0.05 and ∗P < 0.0001, compared to the control.
For clarity reasons, error bars were not applied to the ﬁgure given
that error range was 2–5 %.
forAtorvastatin. Treatmentwith turmeric and PPLincreased
HDL levels signiﬁcantly (P < 0.01), (Table 3). Moreover, all
the treatments decreased signiﬁcantly LDL/HDL ratio (P <
0.05–0.0001).
3.4. Eﬀect of the Natural Extracts on HMG-CoA Reductase
Activity. The eﬀect of the natural extracts on the activity of
HMG-CoA reductase is given in Figure 3. Using three diﬀer-
ent concentrations for each product and for Atorvastatin, as
a positive control, resulted in that Atorvastatin’s three con-
centrations signiﬁcantly inhibited the activity of the enzyme
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Figure 3: Theeﬀect ofthenaturalextractson HMG-CoAreductase
activity at diﬀerent concentrations. Atorva: Atorvastatin; PPL:
prickly pear leaves. Values are presented as means ± S.D. Symbols
mean statistically signiﬁcant; ∗P < 0.05 and ∗∗P < 0.01, compared
to the negative control.
(P < 0.05–0.01). Artichoke’s and PPL’s highest concentra-
tions also inhibited the enzyme’s activity signiﬁcantly (P <
0.05). Although garlic did not have a signiﬁcant eﬀect on the
activity of the enzyme, it is obvious that its inhibitory eﬀect
isconcentrationdependent.Ontheotherhand,turmericdid
not have a signiﬁcant eﬀect on the enzyme’s activity, at the
used concentrations.
4. Discussion
In order to understand the relationship between disorders
in cholesterol metabolism and atherogenesis and to test
possible treatments for the reduction of serum lipid levels,
various models are found to induce hyperlipidemia in
rats [2, 37]. As intrinsic inducer, the surfactant Pluronic
produces massive but reversible hyperlipidemia in rodentsISRN Pharmacology 5
Table 3: The eﬀect of the natural extracts, separately, on serum lipid levels after 7-week period of treatment that included 5 weeks feeding
high-fat diet.
Groups Serum lipid parameters (mg/dL)
Cholesterol Triglycerides HDL LDL LDL/HDL
Control 85 ± 36 5 ± 71 6 ± 27 5 ± 25 . 2 ± 0.5
Atorvastatin 86 ± 34 4 ± 2b 24 ± 37 6 ± 33 . 5 ± 0.5a
Artichoke 79 ± 34 3 ± 3b 21 ± 36 4 ± 3a 3.5 ± 0.5a
Turmeric 75 ± 32 7 ± 1c 29 ± 4b 61 ± 2b 2.5 ± 0.4c
PPL 72 ± 2b 49 ± 12 8 ± 2b 60 ± 3b 2.2 ± 0.1c
Garlic 77 ± 33 5 ± 4c 24 ± 26 2 ± 3b 2.7 ± 0.2b
Datapresentedasmeans ±SEMof8ratsineachgroup.PPL:pricklypearleaves.StatisticalanalysiswasdoneusingANOVA; aP<0.05, bP ≤ 0.01, cP<0.0001,
compared to the control group.
after acute administration [34, 38]. This rise in circulating
lipoproteins levels is caused by modiﬁcations in a number
of biochemical pathways that is involved in lipoprotein
metabolism [34], mainly an increase in serum triglycerides
due to the direct inhibition of lipoprotein lipase which
is the enzyme responsible for triglycerides degradation
[31, 33]. The increase in serum cholesterol is potentially
due to indirect activation of HMG-CoA reductase that is
responsible for cholesterol de novo synthesis [31, 39]. Using
this extreme model of hyperlipidemia induction, PPL, and
garlic decreased signiﬁcantly serum LDL levels whereas the
combination 1 and 2 resulted in decreasing LDL/HDL ratio
as well as PPL and turmeric extracts. Preadministration
of Atorvastatin, on the other hand, did not prevent the
changes induced by Pluronic administration indicating that
the increase in serum cholesterol in such model may not be
due to indirect activating HMG-CoA reductase and/or the
latter has a minor role.
As extrinsic inducer, 10-day high-fat diet caused a sig-
niﬁcant increase in serum cholesterol and LDL, triglycerides
levels and decreased HDL. Pretreating the rats for 14 days
with any of the single products did not prevent or decrease
serum lipid proﬁles. On the other hand, the combinations
artichoke,turmericandPPLorartichoke,turmeric,PPL,and
garlic decreased signiﬁcantly serum triglycerides level, and
LDL/HDLratio;increasedsigniﬁcantlyHDL,andalsomildly
lowered cholesterol and LDL levels by 8–12%, respectively.
Thus, such natural extracts combination for long-term use
would give more signiﬁcant normalization of dyslipidemia.
When the High-Fat diet continued for longer period (5
weeks), it did not increase the total serum cholesterol level
but increased serum LDL and decreased HDL levels. It has
been noticed that after 7–10 days of High-Fat diet feeding,
serum cholesterol, triglyceride, and LDL levels increased
signiﬁcantly in comparison to baseline levels. During the
next 4 weeks of High-Fat diet feeding to rats, it was noticed
that the level of serum cholesterol and triglycerides started to
decrease in the control group as well as the treated groups
but the ratio of LDL/HDL stayed signiﬁcantly high. This
could be explained by that long-term High-Fat diet induces
saturation in cholesterol synthesis inside hepatocytes, and
thus LDL receptor expression is reduced justifying high
LDL serum concentrations [37, 40]. In addition, long-term
treatment of plant sterol with cholesterol might reduce
intestinal cholesterol absorption [41, 42] but this would be
noticed after long-term treatment [43].
Englisch et al. (2000) have reported that the artichoke
extract signiﬁcantly lowered cholesterol and LDL (18.5%
and 22.9%, resp.), in a randomized double-blinded placebo-
control trial in which 143 hypercholesterolemic patients
received either 1800mg/day of the extracts or matched
placebo for six weeks [6, 8]. In this study, artichoke leaves
extracts signiﬁcantly lowered serum triglycerides, LDL, and
LDL/HDL ratio. These modulations are attributed partially
to inhibiting HMG-CoA reductase as seen herein and by
others [5].
We have shown herein that turmeric decreased sig-
niﬁcantly serum triglyceride, LDL, LDL/HDL ratio, and
increased serum HDL level. Although turmeric eﬀect on
serum cholesterol was not signiﬁcant, it decreased its level by
12%. The hypocholesterolemic eﬀect of turmeric has been
widely investigated. In rats fed high-cholesterol diet for 7
days, Arafa (2005) investigated the hypolipidemic eﬀect of
curcumin (0.5% w/w) when added to diet and reported that
curcumin decreased cholesterol by 21% and LDL by 42.5%,
while HDL level was increased by 50% [17]. Another report
has shown that curcumin decreased total cholesterol in
serumby12%andincreasedHDLby29%inhumansubjects
after oral administration of 0.5g/day of curcumin [44]. In
healthy human volunteers receiving 500mg/day curcumin
for 7 days, serum cholesterol was lowered by 11.63% and
HDL level was increased by 29% [45]. The mechanism
by which curcumin aﬀects lipid levels is not related to
HMG-CoA inhibition but could be due to an increase
in the activity of hepatic cholesterol-7a-hydoxylase thereby
enhancing cholesterolcatabolism[12].Othermechanismsof
turmeric may include increasing cholesterol fecal excretion
[19], inducing changes in gene expression involved in
cholesterol homeostasis [20] and through a local eﬀect on
cholesterol absorption [10].
Prickly pear dried leaves signiﬁcantly decreased serum
cholesterol, LDL levels, and LDL/HDL ratio and signif-
icantly increased serum HDL levels. Although its eﬀect
on triglycerides level was not signiﬁcant, PPL decreased
serum triglycerides by 23.5%. Many authors mentioned that
the cladodes of Opuntia ﬁcus indica are utilized for their
hypolipidemic properties [21, 24, 25]. Evidence showed
that cactus pear reduces cholesterol levels in human and6 ISRN Pharmacology
modifyLDLcomposition[22].PricklypearlowersLDLlevels
most likely as a consequence of its pectin content [23].
Rodriguez-Fragoso also clariﬁed that pectin is able to alter
hepatic cholesterol metabolism without aﬀecting cholesterol
absorption [24]. PPL at a dose of 1.6g/meal given to 42
females above 45 years increased serum HDL levels and
decreased triglycerides and LDL levels [35]. In the current
study, PPL signiﬁcantly inhibited the activity of HMG-CoA
reductase and was concentration dependent.
Various extracts of garlic have been shown to lower
serum cholesterol, triglycerides, and LDL in rodents and
humans [26, 46]. Chetty studied the eﬀect of 2% dietary
garlic given to rats fed 1% cholesterol with olive oil.
The results indicated a signiﬁcant decrease in total serum
cholesterol and LDL with an increase in HDL levels [41].
Many authors stated that garlic exert its antihyperlipidemic
eﬀect by inhibiting HMG-CoA reductase and thus inhibit
hepatic cholesterol biosynthesis [28, 36, 47]. In our study,
althoughgarlicdidnothaveasigniﬁcanteﬀectontheactivity
of the enzyme, it is obvious that its inhibitory eﬀect is con-
centration dependent (Figure 3). Other mechanisms include
inhibiting intestinal cholesterol absorption and enhancing
cholesterol turnover to bile acids [36, 48].
Since treating or managing dyslipidemia requires a life-
long use of antihyperlipidemic drugs, it is necessary to use a
combination of natural extracts that exert a similar outcome
withmulti-mechanismofactionandhavelessadverseevents.
Such combination can be used alone as prophylactic, a
booster to a known antihyperlipidemic drugs, or as life-
long phytopharmaceuticals. As presented herein, neither of
the artichoke leaves extract, turmeric extract, prickly pear
dried leaves, and garlic extract showed any eﬀect on short-
term treatment in High-Fat diet model but the combination
eﬀect to normalize dyslipidemia is additive. Thus using the
combination of artichoke leaves extract, turmeric extract,
prickly pear dried leaves, and garlic extract for short-term,
as well as long-term, treatment can prevent dyslipidemia;
partially through inhibiting HMG-CoA reductase.
Conﬂict of Interests
The authors have declared that there is no conﬂict of inter-
ests.
Acknowledgments
This work was supported by a grant from the Deanship of
Scientiﬁc Research at Petra University, Amman, Jordan and
by Delass Natural Products, Naor, Jordan.
References
[1] H. Harnaﬁ, H. Serghini Caid, N. el Houda Bouanani, M.
Aziz, and S. Amrani, “Hypolipemic activity of polyphenol-
rich extracts from Ocimum basilicum in Triton WR-1339-
induced hyperlipidemic mice,” Food Chemistry, vol. 108, no.
1, pp. 205–212, 2008.
[2] S. Bolkent, R. Yanardag, O. Karabulut-Bulan, and B.
Yesilyaprak, “Protective role of Melissa oﬃcinalis L. extract on
liver of hyperlipidemic rats: a morphological and biochemical
study,” Journal of Ethnopharmacology, vol. 99, no. 3, pp. 391–
398, 2005.
[3] V. Lattanzio, P. A. Kroon, V. Linsalata, and A. Cardinali,
“Globe artichoke: a functional food and source of nutraceu-
tical ingredients,” Journal of Functional Foods,v o l .1 ,n o .2 ,p p .
131–144, 2009.
[4] G. Lupattelli, S. Marchesi, R. Lombardini et al., “Artichoke
juice improves endothelial function in hyperlipemia,” Life
Sciences, vol. 76, no. 7, pp. 775–782, 2004.
[5] T. Sa´ enz Rodriguez, D. Garc´ ıa Gim´ enez, and R. de la Puerta
V´ azquez, “Choleretic activity and biliary elimination of lipids
and bile acids induced by an artichoke leaf extract in rats,”
Phytomedicine, vol. 9, no. 8, pp. 687–693, 2002.
[6] W. Englisch, C. Beckers, M. Unkauf, M. Ruepp, and V.
Zinserling, “Eﬃcacy of artichoke dry extract in patients with
hyperlipoproteinemia,” Arzneimittel-Forschung, vol. 50, no. 3,
pp. 260–265, 2000.
[ 7 ]M .H .P i t t l e r ,C .O .T h o m p s o n ,a n dE .E r n s t ,“ A r t i c h o k e
leaf extract for treating hypercholesterolaemia,” Cochrane
Database of Systematic Reviews, no. 3, Article ID CD003335,
2002.
[8] R. Bundy, A. F. Walker, R. W. Middleton, C. Wallis, and H. C.
R. Simpson, “Artichoke leaf extract (Cynara scolymus)r e d u c e s
plasma cholesterol in otherwise healthy hypercholesterolemic
adults: a randomized, double blind placebo controlled trial,”
Phytomedicine, vol. 15, no. 9, pp. 668–675, 2008.
[9] P. Anand, S. G. Thomas, A. B. Kunnumakkara et al., “Biologi-
cal activities of curcumin and its analogues (Congeners) made
by man and mother nature,” Biochemical Pharmacology, vol.
76, no. 11, pp. 1590–1611, 2008.
[10] E. M. Jang, M. S. Choi, U. J. Jung et al., “Beneﬁcial eﬀects of
curcumin on hyperlipidemia and insulin resistance in high-
fat-fed hamsters,” Metabolism, vol. 57, no. 11, pp. 1576–1583,
2008.
[11] A.Goel,A.B.Kunnumakkara,andB.B.Aggarwal,“Curcumin
as “curecumin”: from kitchen to clinic,” Biochemical Pharma-
cology, vol. 75, no. 4, pp. 787–809, 2008.
[12] M. C. Houston, S. Fazio, F. H. Chilton et al., “Nonpharma-
cologic treatment of dyslipidemia,” Progress in Cardiovascular
Diseases, vol. 52, no. 2, pp. 61–94, 2009.
[13] A. Kuhad and K. Chopra, “Curcumin attenuates diabetic
encephalopathy in rats: behavioral and biochemical evi-
dences,” European Journal of Pharmacology, vol. 576, no. 1-3,
pp. 34–42, 2007.
[14] B. B. Aggarwal and K. B. Harikumar, “Potential therapeutic
eﬀects of curcumin, the anti-inﬂammatory agent, against
neurodegenerative, cardiovascular, pulmonary, metabolic,
autoimmune and neoplastic diseases,” International Journal of
Biochemistry and Cell Biology, vol. 41, no. 1, pp. 40–59, 2009.
[15] K. Karthikesan, L. Pari, and V. P. Menon, “Protective
eﬀect of tetrahydrocurcumin and chlorogenic acid against
streptozotocin-nicotinamide generated oxidative stress
induced diabetes,” Journal of Functional Foods, vol. 2, no. 2,
pp. 134–142, 2010.
[16] Q. Kang and A. Chen, “Curcumin suppresses expression
of low-density lipoprotein (LDL) receptor, leading to the
inhibition of LDL-induced activation of hepatic stellate cells,”
BritishJournalofPharmacology,vol.157,no.8,pp.1354–1367,
2009.
[17] H. M. M. Arafa, “Curcumin attenuates diet-induced hyperc-
holesterolemia in rats,” Medical Science Monitor,v o l .1 1 ,n o .7 ,
pp. BR228–BR234, 2005.ISRN Pharmacology 7
[18] R. Rukkumani, M. Sri Balasubashini, P. Vishwanathan, and
V. P. Menon, “Comparative eﬀects of curcumin and photo-
irradiated curcumin on alcohol- and polyunsaturated fatty
acid-induced hyperlipidemia,” Pharmacological Research, vol.
46, no. 3, pp. 257–264, 2002.
[19] D. S. Rao, N. C. Sekhara, M. N. Satyanarayana, and M.
Srinivasan, “Eﬀe c to fc u r c u m i no ns e r u ma n dl i v e rc h o l e s t e r o l
levels in the rat,” Journal of Nutrition, vol. 100, no. 11, pp.
1307–1315, 1970.
[20] D. Peschel, R. Koerting, and N. Nass, “Curcumin induces
changes in expression of genes involved in cholesterol home-
ostasis,” Journal of Nutritional Biochemistry,v o l .1 8 ,n o .2 ,p p .
113–119, 2007.
[21] M. de Leo, M. B. D. Abreu, A. M. Pawlowska, P. L. Cioni,
and A. Braca, “Proﬁling the chemical content of Opuntia
ﬁcus-indica ﬂowers by HPLC-PDA-ESI-MS and GC/EIMS
analyses,” PhytochemistryLetters,vol.3, no.1,pp.48–52, 2010.
[22] M. F. Ramadan and J. T. M¨ orsel, “Oil cactus pear (Opuntia
ﬁcus-indica L.),” Food Chemistry, vol. 82, no. 3, pp. 339–345,
2003.
[23] R. Wolfram, A. Budinsky, Y. Efthimiou, J. Stomatopoulos, A.
Oguogho, and H. Sinzinger, “Daily prickly pear consumption
improves platelet function,” Prostaglandins Leukotrienes and
Essential Fatty Acids, vol. 69, no. 1, pp. 61–66, 2003.
[24] L. Rodriguez-Fragoso, J. Reyes-Esparza, S. W. Burchiel, D.
Herrera-Ruiz, and E. Torres, “Risks and beneﬁts of commonly
used herbal medicines in Mexico,” Toxicology and Applied
Pharmacology, vol. 227, no. 1, pp. 125–135, 2008.
[25] M. Ennouri, H. Fetoui, E. Bourret, N. Zeghal, and H. Attia,
“Evaluation of some biological parameters of Opuntia ﬁcus
indica. 1. Inﬂuence of a seed oil supplemented diet on rats,”
Bioresource Technology, vol. 97, no. 12, pp. 1382–1386, 2006.
[26] K. Rahman, “Garlic and aging: new insights into an old
remedy,” Ageing Research Reviews, vol. 2, no. 1, pp. 39–56,
2003.
[ 2 7 ]V .K e s h e t t y ,R .G .S r i n i v a s P a b b a ,J .M .K a n d u k u r i ,a n dV .
Allenki, “Antihyperlipidemic activity of methanolic extract of
garlic (Allium sativum L.) in triton X-100 induced hyperlipi-
demic rats,” Journal of Pharmacy Research, vol. 2, no. 5, pp.
777–780, 2009.
[28] M. P. McRae, “A review of studies of garlic (Allium sativum)
onserumlipidsandbloodpressurebeforeandafter1994:does
the amount of allicin released from garlic powder tablets play
a role?” Journal of Chiropractic Medicine, vol. 4, no. 4, pp. 182–
190, 2005.
[29] H. Wagner and G. Ulrich-Merzenich, “Synergy research:
approaching a new generation of phytopharmaceuticals,”
Phytomedicine, vol. 16, no. 2-3, pp. 97–110, 2009.
[30] N. Qinna, H. Taha, K. Z. Matalka, and A. A. Badwan, “A new
herbal combination, etana, for enhancing erectile function: an
eﬃcacy and safety study in animals,” International Journal of
Impotence Research, vol. 21, no. 5, pp. 315–320, 2009.
[ 3 1 ]H .J .J u n g ,J .H .N a m ,H .J .P a r ke ta l . ,“ T h eM e O He x t r a c t
of Pleurospermum kamtschaticum and its active component
buddlejasaponin (IV) inhibits intrinsic and extrinsic hyper-
lipidemia and hypercholesterolemia in the rat,” Journal of
Ethnopharmacology, vol. 112, no. 2, pp. 255–261, 2007.
[32] T. P. Johnston and W. K. Palmer, “Eﬀect of poloxamer 407 on
the activity of microsomal 3-hydroxy-3- methylglutaryl CoA
reductaseinrats,”JournalofCardiovascularPharmacology,vol.
29, no. 5, pp. 580–585, 1997.
[33] S. Megalli, F. Aktan, N. M. Davies, and B. D. Roufogalis,
“Phytopreventive anti-hyperlipidemic eﬀects of Gynostemma
pentaphylluminrats,”JournalofPharmacyandPharmaceutical
Sciences, vol. 8, no. 3, pp. 507–515, 2005.
[ 3 4 ]A .S h a y e g a n p o u r ,H .K o r a s h y ,J .P .P a t e l ,A .O .S .E l - K a d i ,a n d
D. R. Brocks, “The impact of experimental hyperlipidemia
on the distribution and metabolism of amiodarone in rat,”
International Journal of Pharmaceutics, vol. 361, no. 1-2, pp.
78–86, 2008.
[35] E. Linar` es, C. Thimonier, and M. Degre, “The eﬀect of
NeOpuntia on blood lipid parameters—risk factors for the
metabolicsyndrome(SyndromeX),”AdvancesinTherapy,vol.
24, no. 5, pp. 1115–1125, 2007.
[36] C. Ulbricht, E. Basch, S. Basch, and J. K. Bryan, “An evidence-
based review of garlic and its hypolipidemic properties by the
natural standard research collaboration scientiﬁc evidence for
common/studied uses,” Medicine, vol. 2, pp. 1–7, 2010.
[37] S. L. Matos, H. de Paula, M. L. Pedrosa et al., “Dietary models
for inducing hypercholesterolemia in rats,” Brazilian Archives
of Biology and Technology, vol. 48, no. 2, pp. 203–209, 2005.
[ 3 8 ]V .C .C o g g e r ,S .N .H i l m e r ,D .S u l l i v a n ,M .M u l l e r ,R .F r a s e r ,
and D. G. Le Couteur, “Hyperlipidemia and surfactants: the
liver sieve is a link,” Atherosclerosis, vol. 189, no. 2, pp. 273–
281, 2006.
[39] T. P. Johnston and W. K. Palmer, “Mechanism of poloxamer
407-induced hypertriglyceridemia in the rat,” Biochemical
Pharmacology, vol. 46, no. 6, pp. 1037–1042, 1993.
[ 4 0 ]J .M .B e r g ,J .L .T y m o c z k o ,a n dL .S t r y e r ,Biochemistry,W .H .
Freeman, New York, NY, USA, 5th edition, 2002.
[41] K. N. Chetty, L. Calahan, K. C. Harris et al., “Garlic attenuates
hypercholesterolemic risk factors in olive oil fed rats and high
cholesterol fed rats,” Pathophysiology, vol. 9, no. 3, pp. 127–
132, 2003.
[42] L. H. Elleg˚ ard, S. W. Andersson, A. L. Norm´ en, and H. A.
Andersson, “Dietary plant sterols and cholesterol metabo-
lism,” Nutrition Reviews, vol. 65, no. 1, pp. 39–45, 2007.
[43] G. Garc´ ıa-Llatas and M. T. Rodr´ ıguez-Estrada, “Current and
new insights on phytosterol oxides in plant sterol-enriched
food,” Chemistry and Physics of Lipids, vol. 164, no. 6, pp. 607–
624, 2011.
[44] L. Baum, S. K. K. Cheung, V. C. T. Mok et al., “Curcumin
eﬀects on blood lipid proﬁle in a 6-month human study,”
Pharmacological Research, vol. 56, no. 6, pp. 509–514, 2007.
[45] K. B. Soni and R. Kuttan, “Eﬀect of oral curcumin adminis-
tration on serum peroxides and cholesterol levels in human
volunteers,” Indian Journal of Physiology and Pharmacology,
vol. 36, no. 4, pp. 273–275, 1992.
[46] M. J. Budoﬀ, N. Ahmadi, K. M. Gul et al., “Aged garlic
extract supplemented with B vitamins, folic acid and l-
arginine retards the progression of subclinical atherosclerosis:
a randomized clinical trial,” Preventive Medicine, vol. 49, no.
2-3, pp. 101–107, 2009.
[47] I. Durak, M. Kavutcu, B. Aytac ¸ et al., “Eﬀects of garlic
extract consumption on blood lipid and oxidant/antioxidant
parameters in humans with high blood cholesterol,” Journal of
Nutritional Biochemistry, vol. 15, no. 6, pp. 373–377, 2004.
[48] M. Corzo-Martinez, N. Corzo, and M. Villamiel, “Biological
properties of onions and garlic,” Trends in Food Science and
Technology, vol. 18, no. 12, pp. 609–625, 2007.Submit your manuscripts at
http://www.hindawi.com
Pain
Research and Treatment
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
Volume 2014
Toxins
Journal of
Vaccines
Journal of
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Antibiotics
International Journal of
Toxicology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Stroke
Research and Treatment
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Drug Delivery
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Advances in 
Pharmacological 
Sciences
Tropical Medicine
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Medicinal Chemistry
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Addiction
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Emergency Medicine 
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
  Autoimmune 
Diseases
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Anesthesiology 
Research and Practice
Scientifica
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Pharmaceutics
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of